Clinical significance of early kinetics of C‑reactive protein in patients with advanced urothelial carcinoma treated with pembrolizumab: Flare response and baseline levels predict oncological outcomes

Ikko Tomisaki, Mirii Harada, Shigeru Sakano, Michikazu Terado, Ryoichi Hamasuna, Shuji Harada, Hiroomi Matsumoto, Soichiro Akasaka, Yujiro Nagata, Akinori Minato, Ken-Ichi Harada, Naohiro Fujimoto

Open source

DOI
10.3892/ol.2024.14736
Published
2024-10-11
Container
Oncology Letters
Publisher
Spandidos Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ol.2024.14736,
  title = {Clinical significance of early kinetics of C‑reactive protein in patients with advanced urothelial carcinoma treated with pembrolizumab: Flare response and baseline levels predict oncological outcomes},
  author = {Ikko Tomisaki and Mirii Harada and Shigeru Sakano and Michikazu Terado and Ryoichi Hamasuna and Shuji Harada and Hiroomi Matsumoto and Soichiro Akasaka and Yujiro Nagata and Akinori Minato and Ken-Ichi Harada and Naohiro Fujimoto},
  year = {2024},
  journal = {Oncology Letters},
  doi = {10.3892/ol.2024.14736},
  url = {https://doi.org/10.3892/ol.2024.14736}
}

RIS

TY  - JOUR
TI  - Clinical significance of early kinetics of C‑reactive protein in patients with advanced urothelial carcinoma treated with pembrolizumab: Flare response and baseline levels predict oncological outcomes
AU  - Ikko Tomisaki
AU  - Mirii Harada
AU  - Shigeru Sakano
AU  - Michikazu Terado
AU  - Ryoichi Hamasuna
AU  - Shuji Harada
AU  - Hiroomi Matsumoto
AU  - Soichiro Akasaka
AU  - Yujiro Nagata
AU  - Akinori Minato
AU  - Ken-Ichi Harada
AU  - Naohiro Fujimoto
PY  - 2024
JO  - Oncology Letters
DO  - 10.3892/ol.2024.14736
UR  - https://doi.org/10.3892/ol.2024.14736
ER  - 

APA

Tomisaki, I., Harada, M., Sakano, S., Terado, M., Hamasuna, R., Harada, S., Matsumoto, H., Akasaka, S., Nagata, Y., Minato, A., Harada, K., & Fujimoto, N. (2024). Clinical significance of early kinetics of C‑reactive protein in patients with advanced urothelial carcinoma treated with pembrolizumab: Flare response and baseline levels predict oncological outcomes. Oncology Letters. https://doi.org/10.3892/ol.2024.14736

Source records